FIGURE 5
Synergistic targeting of proteasome and ferroptosis pathways underlies RIF’s anti-leukemic efficacy. Functional dissection identifies RIF-driven pathway perturbations:
FIGURE 5
Synergistic targeting of proteasome and ferroptosis pathways underlies RIF’s anti-leukemic efficacy. Functional dissection identifies RIF-driven pathway perturbations: